Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis.

A Regev1, E R Schiff

  • 1Center for Liver Diseases, Miami, Florida, USA.

Current Opinion in Gastroenterology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Recent advances in viral hepatitis research highlight improved understanding of antiviral drug mechanisms and resistance. New combination therapies show promise for chronic hepatitis B and C, with enhanced vaccines and transplantation strategies for hepatitis A and B.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A self-adaptive hardware with resistive switching synapses for experience-based neurocomputing.

Nature communications·2023
Same author

SM-Omics is an automated platform for high-throughput spatial multi-omics.

Nature communications·2022
Same author

Application of ventricular tachyarrhythmia definitions of the updated Lambeth Conventions provides incompatibility with earlier results, masks antifibrillatory activity and reduces inter-observer agreement.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2019
Same author

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Human genetics·2018
Same author

Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib.

Clinical pharmacology and therapeutics·2015
Same author

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.

Journal of viral hepatitis·2015
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Viral hepatitis remains a significant global cause of acute and chronic liver disease.
  • Recent molecular biology and clinical studies have advanced understanding of viral hepatitis.
  • Hepatitis A poses risks to patients with chronic liver disease, necessitating effective prevention.

Purpose of the Study:

  • To review recent advances in the understanding and management of viral hepatitis A through G.
  • To focus on key developments reported in the past year.
  • To highlight progress in antiviral therapies, vaccines, and liver transplantation.

Main Methods:

  • Comprehensive review of recent scientific literature (past year).
  • Analysis of molecular biology and clinical studies.

Related Experiment Videos

  • Synthesis of findings on antiviral drug mechanisms, resistance, and treatment strategies.

    • Main Results:

    • Efficacy of hepatitis A vaccines in patients with chronic liver disease confirmed.
    • Aggressive combination therapy shows promise for chronic hepatitis B and C.
    • Improved immune prophylaxis techniques for hepatitis B and new strategies for post-transplant recurrence.

    Conclusions:

    • Significant progress has been made in managing viral hepatitis.
    • Combination therapies and improved prophylactic measures offer new hope.
    • Liver transplantation is a routine option for end-stage hepatitis B, with ongoing research into recurrence prevention.